Dermatology Groups

Psoriasis Treatment Planner

Research: Award Submissions

Dominant · Search Engine Appearances ρ=0.424

AI recommendation signal analysis across 195 domains for the Psoriasis Treatment Planner persona in Dermatology Groups.

Link authority data (PageRank, harmonic centrality) comes from the Common Crawl web graph.

Download this report (.xlsx)

195Domains Tracked

6.7MReddit Posts

7,796Wikipedia Articles

1.4MOpen Web Matches

Psoriasis Treatment Planner_persona.report

DomainScore

psoriasis.org

1.4

practicaldermatology.com

0.2

osr.ucsf.edu

0.1

Domains rankedn = 3

This is a shortened preview of the Dermatology Groups report

Many tables and charts on this page show only the top few results; the full data behind them runs far deeper. The complete report unlocks every row, chart, and download for this industry.

Get the full Dermatology Groups report →

About This Report

How to use this page

Persona view: this page is scoped to this persona's queries alone.

Use Case

Win awards worth having

These results surface the awards active in this industry. Shortlist the credible ones and submit: wins earn trust signals, links, and the kind of third-party validation LLMs and buyers both cite.

How It's Calculated

Where the numbers come from

We run award submissions queries for this industry through Google and aggregate every result: domains by rank-weighted score (higher positions count for more) and appearance count, exact URLs by appearance count, and the most common title phrases.

Overview

What's on this page

Domain and URL charts, the full result list, and title n-gram tables.

Research

Research: Award Submissions

Domains appearing in Google results for Psoriasis Treatment Planner's Research: Award Submissions queries. Score is a rank-weighted sum (higher-ranked appearances count for more); count is a plain appearance tally.

By Score

Top URLs

Individual pages (not just domains) ranked by the same rank-weighted score, labeled by page title.

By Appearance Count

All Results

Every result for Psoriasis Treatment Planner's Research: Award Submissions queries, ranked by how many times each exact URL appeared (ties broken by average rank position, so appearing higher up wins), a different aggregation than the score-based charts above. Title and URL links open in a new tab.

Title	URL	Appearances	Domain PR	Domain HC	Host PR	Host HC

Psoriasis Association – PRUK Research Award	https://pharmacyresearchuk.org/psoriasis-association-pruk-research-award/	2	7	95	3	94
Submit a Manuscript - Psoriasis: Targets and Therapy	https://www.dovepress.com/submit_to_journal.php?tf_code=DPTT	2	40	96	2	94
FDA approval of ICOTYDE™ (icotrokinra) ushers in new era ...	https://www.investor.jnj.com/investor-news/news-details/2026/FDA-approval-of-ICOTYDE-icotrokinra-ushers-in-new-era-for-first-line-systemic-treatment-of-plaque-psoriasis-with-a-targeted-oral-peptide/default.aspx	2	44	96	0	94

Phrase Frequency

Title N-Grams

Most common word phrases (2 to 7 words) across every result title for these queries.

2-grams

17	psoriasis foundation
16	national psoriasis
7	medical professional
7	professional award
7	seal of
6	award winners
5	foundation awards
5	research award
5	psoriasis treatment
4	of recognition
4	the national
4	grant and
3	psoriasis clinical
3	foundation honors
3	fda approval
3	new era
3	million in
3	and treatment
3	medical professionals
3	npf grant
3	and fellowship
2	award program
2	submission guidelines
2	of psoriasis
2	psoriasis association

3-grams

16	national psoriasis foundation
7	medical professional award
6	professional award winners
5	psoriasis foundation awards
4	seal of recognition
4	the national psoriasis
3	psoriasis foundation honors
3	npf grant and
3	grant and fellowship
2	psoriasis association pruk
2	association pruk research
2	pruk research award
2	submit a manuscript
2	a manuscript psoriasis
2	manuscript psoriasis targets
2	psoriasis targets and
2	targets and therapy
2	criteria for identifying
2	for identifying candidates
2	identifying candidates for
2	candidates for systemic
2	for systemic psoriasis
2	moderate to severe
2	fda approval of
2	approval of icotyde

4-grams

6	medical professional award winners
5	national psoriasis foundation awards
4	the national psoriasis foundation
3	npf grant and fellowship
2	psoriasis association pruk research
2	association pruk research award
2	submit a manuscript psoriasis
2	a manuscript psoriasis targets
2	manuscript psoriasis targets and
2	psoriasis targets and therapy
2	criteria for identifying candidates
2	for identifying candidates for
2	identifying candidates for systemic
2	candidates for systemic psoriasis
2	national psoriasis foundation honors
2	fda approval of icotyde
2	approval of icotyde icotrokinra
2	of icotyde icotrokinra ushers
2	icotyde icotrokinra ushers in
2	icotrokinra ushers in new
2	ushers in new era
2	national psoriasis foundation announces
2	national psoriasis foundation hosts
2	psoriasis foundation hosts their
2	foundation hosts their largest

5-grams

2	psoriasis association pruk research award
2	submit a manuscript psoriasis targets
2	a manuscript psoriasis targets and
2	manuscript psoriasis targets and therapy
2	criteria for identifying candidates for
2	for identifying candidates for systemic
2	identifying candidates for systemic psoriasis
2	fda approval of icotyde icotrokinra
2	approval of icotyde icotrokinra ushers
2	of icotyde icotrokinra ushers in
2	icotyde icotrokinra ushers in new
2	icotrokinra ushers in new era
2	the national psoriasis foundation hosts
2	national psoriasis foundation hosts their
2	psoriasis foundation hosts their largest
2	therapeutic goals and treatment response
2	goals and treatment response evaluation
2	and treatment response evaluation in
2	2022 medical professional award winners
2	arcutis zoryve roflumilast topical foam
2	zoryve roflumilast topical foam 0
2	roflumilast topical foam 0 3
2	medical professionals recognized for their
2	npf grant and fellowship awards
1	npf medical professional award program

6-grams

2	submit a manuscript psoriasis targets and
2	a manuscript psoriasis targets and therapy
2	criteria for identifying candidates for systemic
2	for identifying candidates for systemic psoriasis
2	fda approval of icotyde icotrokinra ushers
2	approval of icotyde icotrokinra ushers in
2	of icotyde icotrokinra ushers in new
2	icotyde icotrokinra ushers in new era
2	the national psoriasis foundation hosts their
2	national psoriasis foundation hosts their largest
2	therapeutic goals and treatment response evaluation
2	goals and treatment response evaluation in
2	arcutis zoryve roflumilast topical foam 0
2	zoryve roflumilast topical foam 0 3
1	national psoriasis foundation awards zoryve seal
1	psoriasis foundation awards zoryve seal of
1	npf expands seal of recognition to
1	expands seal of recognition to fda
1	seal of recognition to fda approved
1	submission guidelines journal of psoriasis and
1	guidelines journal of psoriasis and psoriatic
1	bristol myers squibb psoriasis research award
1	npf awards six research grants to
1	awards six research grants to scientists
1	six research grants to scientists studying

7-grams

2	submit a manuscript psoriasis targets and therapy
2	criteria for identifying candidates for systemic psoriasis
2	fda approval of icotyde icotrokinra ushers in
2	approval of icotyde icotrokinra ushers in new
2	of icotyde icotrokinra ushers in new era
2	the national psoriasis foundation hosts their largest
2	therapeutic goals and treatment response evaluation in
2	arcutis zoryve roflumilast topical foam 0 3
1	national psoriasis foundation awards zoryve seal of
1	npf expands seal of recognition to fda
1	expands seal of recognition to fda approved
1	submission guidelines journal of psoriasis and psoriatic
1	npf awards six research grants to scientists
1	awards six research grants to scientists studying
1	national psoriasis foundation awards half a million
1	psoriasis foundation awards half a million dollars
1	popsugar s 2026 skin care awards submission
1	s 2026 skin care awards submission guidelines
1	for those who uplift and empower the
1	those who uplift and empower the next
1	who uplift and empower the next generation
1	uplift and empower the next generation of
1	fda approves icotyde as treatment of moderate
1	approves icotyde as treatment of moderate to
1	icotyde as treatment of moderate to severe